News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boehringer Ingelheim Pharmaceuticals, Inc. to Pay $95 Million to Resolve Drug Promo Case


10/26/2012 6:21:57 AM

Boehringer Ingelheim Pharmaceuticals | Jobs at Boehringer Ingelheim Pharmaceuticals

Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle government claims it improperly promoted four drugs, the U.S. Justice Department said.

The accord ends a federal False Claims Act lawsuit in Maryland filed by Robert Heiden, a former company sales representative, the government said today in a statement. Heiden will get $17 million for his role as whistle-blower.

Read at Bloomberg
Read at NPR News
Read at ABC News
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES